Woven Science
- Company typePrivate
- Founded2021
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
Woven Science firmographics
Firmographics- Name
- Woven Science
- Legal name
- Woven Science
- Website
- https://woven.science
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Woven Science industry classification
Industry- Product category
- Psychedelic Wellness Investment
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Professional, Scientific, and Technical Services (541), Medicinal and Botanical Manufacturing (325411)
- SIC
- Services-Commercial Physical & Biological Research (8731), Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Mental Wellness & Resilience Education (Non-clinical) (EDAAAHAK)
- akta.pro secondary industries
- Meditation Apps, Digital Courses & Online Communities (HSADAJAH), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Botanical/Herbal & Adaptogen Functional Beverage Production (AFAFAFAF), Mindfulness, Meditation & Stress Management Education (EDAAAHAD)
Keywords
Where Woven Science is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Woven Science business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Distribution channels1 record
Marketing channels3 records
Woven Science product offering
Product offeringCore offering
Woven Science backs and builds psychedelic and wellness companies through three integrated pillars: Woven Labs (drug development, health technology investment, and an accelerator/incubation program), Woven Wellness (plant-medicine and wellbeing product development and distribution), and El Puente (a foundation plus DAO that dedicates 10% of company equity to indigenous benefit-sharing through grants, education, regeneration, and sovereignty initiatives). The company invests in and operates portfolio companies that address unmet needs across the mental health treatment arc.
Product overview
Woven Science is a psychedelic and wellness investment and development company operating as a unified platform built on three core pillars: Woven Labs (drug development, health technology investment, incubation, and acceleration), Woven Wellness (plant-medicine and wellbeing product development and distribution), and El Puente (indigenous benefit-sharing and reciprocity initiative). The company backs and builds leading psychedelic and wellness companies, targeting unmet needs across every stage of the treatment arc.
Differentiator
Problem solved
Functional benefit
Brands
- Woven Labs: Supporting mission-adjacent companies in drug development, delivery and health technology investment, incubation, and acceleration.
- Woven Wellness
- El Puente
Products and services
- Woven Labs Investment and incubation arm of Woven Science that supports mission-adjacent companies in drug development, delivery, and health technology through equity investment and an accelerator program, intended for founders of psychedelic and wellness companies seeking capital and operational support.
- Woven Wellness Plant-medicine and wellbeing product development and distribution division of Woven Science, creating consumer wellness offerings within the company's psychedelic care platform.
- El Puente Foundation initiative of Woven Science that allocates 10% of company equity to facilitate grants and investments into indigenous-owned projects across four pillars: reciprocity, education, regeneration, and sovereignty, governed by a council of indigenous leaders with vote and veto powers.
- El Puente DAO Decentralized autonomous organization associated with the El Puente initiative, providing a community-based platform to engage members in access and benefit-sharing for indigenous communities in the psychedelic sector.
Companies that use Woven Science
Customer profileSegments2 records
Ideal customer profiles2 records
Woven Science technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Woven Science partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered minor and core.
- Swiss drug development firm (unnamed)minorWoven Science co-led an investment in a Swiss drug development firm as part of their portfolio strategy across multiple countries.
- MCKA (Multicultural Cannabis Knowledge Alliance)coreBeneficiary of El Puente foundation grants and investments, focusing on indigenous capacity building and knowledge sharing.
- RSF (Rainforest Seed)coreBeneficiary of El Puente foundation, involved in regeneration and ecosystem protection initiatives.
- BGDcoreBeneficiary of El Puente foundation grants supporting indigenous-owned projects.
- Kene RaocoreBeneficiary of El Puente foundation focusing on indigenous capacity building.
- The FountaincoreBeneficiary of El Puente foundation grants and investments.
- ICEERS (International Center for Ethnobotanical Education, Research and Service)coreBeneficiary of El Puente foundation, involved in education and preservation initiatives in psychedelics sector.
Scale indicators2 records
Recent moves5 records
Expansion highlights4 records
Woven Science competitors and assessment
Company assessmentDirect peers
- Compass Pathways: Public clinical-stage psychedelic medicine company developing psilocybin therapy for treatment-resistant depression. Direct peer because both are building portfolios/platforms around psychedelic-assisted mental health treatment, though Compass is focused on a single clinical asset.
- Atai Life Sciences: Public clinical-stage platform company developing psychedelic and non-psychedelic compounds for mental health. Closely comparable venture-platform model with multiple portfolio companies, drug development focus, and mental wellness thesis.
- MindMed: Public psychedelic medicine company developing psychedelic-inspired and psychedelic-derived therapies. Direct competitor in the psychedelic therapeutics space with overlapping drug development pipeline and mental health focus.
- Cybin: Public psychedelic therapeutics company developing psilocybin-based treatments for depression and addiction. Direct peer sharing Woven's psychedelic drug development and mental wellness mission.
- Beckley Psytech: Private psychedelic medicine company developing psilocybin and DMT-based therapies. Comparable as a psychedelic-focused drug development company targeting mental health indications.
- Field Trip Health: Operator of psychedelic-assisted therapy clinics and developer of psilocybin-based treatments. Direct peer in Woven's clinic and treatment-arc coverage, though Field Trip exited clinic operations in 2023.
- GH Research: Public clinical-stage company developing DMT-based therapies for treatment-resistant depression. Direct peer in psychedelic drug development for mental health, though focused on a single compound (DMT).
Broad incumbents
- MAPS (Multidisciplinary Association for Psychedelic Studies): Long-standing nonprofit research organization that has driven much of the modern psychedelic therapy field, including MDMA-assisted therapy for PTSD. Comparable as a broader force shaping the psychedelic sector Woven is building into.
Others
- Noetic Fund: Specialized venture fund focused on psychedelic medicine and mental health companies; led Woven Science's seed round. Investor and ecosystem enabler rather than direct competitor, but highly comparable as a psychedelic-focused capital platform.
Emerging players
- Silo Wellness: Public psychedelic wellness company developing psilocybin products and retreat experiences. Emerging peer in the wellness/plant-medicine portion of Woven's platform, though with narrower scope.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Woven Science social profiles
Digital presenceWoven Science financial estimates
Financial estimateRevenue estimate
Valuation estimate
Woven Science leadership team
Management profileNumber of profiles
Profiles8 records
Woven Science funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Woven Science M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Woven Science
What does Woven Science do?
Woven Science backs and builds psychedelic and wellness companies through three integrated pillars: Woven Labs (drug development, health technology investment, and an accelerator/incubation program), Woven Wellness (plant-medicine and wellbeing product development and distribution), and El Puente (a foundation plus DAO that dedicates 10% of company equity to indigenous benefit-sharing through grants, education, regeneration, and sovereignty initiatives). The company invests in and operates portfolio companies that address unmet needs across the mental health treatment arc.
Is Woven Science a public or private company?
Woven Science is a private company. It is classified as venture growth investor backed and is currently operating.
When was Woven Science founded?
Woven Science was founded in 2021. It employs 11 to 50 people.
Where is Woven Science based?
Woven Science is headquartered in New York, United States, in the North America region.
Who are Woven Science's main competitors?
Direct peers on record are Compass Pathways, Atai Life Sciences, MindMed, Cybin, Beckley Psytech, Field Trip Health and GH Research. MAPS (Multidisciplinary Association for Psychedelic Studies) is listed as a broad incumbent. Noetic Fund is listed as an others. Silo Wellness is listed as an emerging player.
Does Woven Science have an API?
No public API is recorded for Woven Science.
What industry is Woven Science in?
Woven Science's product category is Psychedelic Wellness Investment. Its primary akta.pro industry code is EDAAAHAK, Mental Wellness & Resilience Education (Non-clinical), with a secondary code of HSADAJAH, Meditation Apps, Digital Courses & Online Communities. Its NAICS code is 541714 and its SIC code is 8731.